UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial

The Journal of urology, 2009-09, Vol.182 (3), p.1055-1061

2009

Volltextzugriff (PDF)

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of urology, 2009-04, Vol.181 (4), p.1764-1772

2009

Volltextzugriff (PDF)

Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study

Neurourology and urodynamics, 2013-01, Vol.32 (1), p.24-29

2013

Volltextzugriff (PDF)

Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?

BJU international, 2007-06, Vol.99 (s3), p.8-12

MacDiarmid, Scott A.

2007

Volltextzugriff (PDF)

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

European urology, 2013-08, Vol.64 (2), p.249-256

2013

Volltextzugriff (PDF)

pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing

European journal of clinical pharmacology, 2010-02, Vol.66 (2), p.171-176

2010

Volltextzugriff (PDF)

Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder

Urology (Ridgewood, N.J.), 2011, Vol.77 (1), p.24-29

2011

Volltextzugriff (PDF)

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

European urology, 2016-07, Vol.70 (1), p.136-145

2016

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF EXTENDED RELEASE OXYBUTYNIN FOR THE TREATMENT OF URGE INCONTINENCE: AN ANALYSIS OF DATA FROM 3 FLEXIBLE DOSING STUDIES

The Journal of urology, 2005-10, Vol.174 (4), p.1301-1305

2005

Volltextzugriff (PDF)

Anuria due to bilateral ureteral obstruction by Aspergillus flavus in an adult male

Urology (Ridgewood, N.J.), 2002-04, Vol.59 (4), p.601-601

2002

Volltextzugriff (PDF)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

International journal of clinical practice (Esher), 2017-05, Vol.71 (5), p.e12944-n/a

2017

Volltextzugriff (PDF)

Assessment of a new transurethral balloon dilation catheter in the treatment of urethral stricture disease

Urology (Ridgewood, N.J.), 2000-03, Vol.55 (3), p.408-413

2000

Volltextzugriff (PDF)

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder

International Urogynecology Journal, 2014-12, Vol.25 (12), p.1655-1663

2014

Volltextzugriff (PDF)

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Current urology reports, 2012-10, Vol.13 (5), p.327-334

2012

Volltextzugriff (PDF)

Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected]

The Journal of urology, 2016-09, Vol.196 (3), p.809-818

2016

Volltextzugriff (PDF)

Overactive bladder in women: symptom impact and treatment expectations

Current medical research and opinion, 2005-09, Vol.21 (9), p.1413-1421

2005

Volltextzugriff (PDF)

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial

The patient : patient-centered outcomes research, 2017-12, Vol.10 (6), p.677-686

2017

Volltextzugriff (PDF)

Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool

BMC neurology, 2013-07, Vol.13 (1), p.78-78, Article 78

2013

Volltextzugriff (PDF)

Male overactive bladder: the role of urodynamics and anticholinergics

Current urology reports, 2007-01, Vol.8 (1), p.66-73

2007

Volltextzugriff (PDF)

Perceptions and behaviours of women with bladder control problems

Family practice, 2006-10, Vol.23 (5), p.568-577

2006

Volltextzugriff (PDF)

Interstitial cystitis: the painful bladder syndrome

Current pain and headache reports, 2000, Vol.4 (2), p.137-141

2000

Volltextzugriff (PDF)

The clinical efficacy of tolterodine extended‐release is maintained for 24 h in patients with overactive bladder

BJU international, 2007-07, Vol.100 (1), p.107-110

2007

Volltextzugriff (PDF)

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder

International Urogynecology Journal, 2006-10, Vol.17 (5), p.502-511

2006

Volltextzugriff (PDF)

Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials

International urology and nephrology, 2007-12, Vol.39 (4), p.1069-1077

2007

Volltextzugriff (PDF)

Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of Extended-Release Formulations of Oxybutynin and Tolterodine

Journal of clinical pharmacology, 2005-08, Vol.45 (8), p.961-968

2005

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Humans
(37)
Middle Aged
(32)
Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Male
(30)
Female
(29)
Aged
(27)
Aged, 80 And Over
(18)
Urology & Nephrology
(17)
Urinary Bladder, Overactive - Drug Therapy
(12)
Urinary Incontinence
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Overactive Bladder
(11)
Treatment Outcome
(11)
Adolescent
(10)
Double-Blind Method
(10)
Urology
(9)
Young Adult
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study

Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing

Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

EFFICACY AND SAFETY OF EXTENDED RELEASE OXYBUTYNIN FOR THE TREATMENT OF URGE INCONTINENCE: AN ANALYSIS OF DATA FROM 3 FLEXIBLE DOSING STUDIES

Anuria due to bilateral ureteral obstruction by Aspergillus flavus in an adult male

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

Assessment of a new transurethral balloon dilation catheter in the treatment of urethral stricture disease

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected]

Overactive bladder in women: symptom impact and treatment expectations

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial

Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool

Male overactive bladder: the role of urodynamics and anticholinergics

Perceptions and behaviours of women with bladder control problems

Interstitial cystitis: the painful bladder syndrome

The clinical efficacy of tolterodine extended‐release is maintained for 24 h in patients with overactive bladder

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder

Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials

Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of Extended-Release Formulations of Oxybutynin and Tolterodine

Aktive Filter

Suchergebnisse filtern